These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24846237)

  • 1. Microparticles as biomarkers of vascular dysfunction in metabolic syndrome and its individual components.
    Agouni A; Andriantsitohaina R; Martinez MC
    Curr Vasc Pharmacol; 2014 May; 12(3):483-92. PubMed ID: 24846237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases.
    Berezin A; Zulli A; Kerrigan S; Petrovic D; Kruzliak P
    Clin Biochem; 2015 Jun; 48(9):562-8. PubMed ID: 25697107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases.
    Meziani F; Tesse A; Andriantsitohaina R
    Pharmacol Rep; 2008; 60(1):75-84. PubMed ID: 18276988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes.
    Benameur T; Osman A; Parray A; Ait Hssain A; Munusamy S; Agouni A
    Oxid Med Cell Longev; 2019; 2019():6475187. PubMed ID: 30915196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Microparticles Are Elevated in Treated HIV -1 Infection and Are Deleterious to Endothelial Cell Function.
    Hijmans JG; Stockelman KA; Garcia V; Levy MV; Brewster LM; Bammert TD; Greiner JJ; Stauffer BL; Connick E; DeSouza CA
    J Am Heart Assoc; 2019 Feb; 8(4):e011134. PubMed ID: 30779672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticles as potential biomarkers of cardiovascular disease.
    França CN; Izar MC; Amaral JB; Tegani DM; Fonseca FA
    Arq Bras Cardiol; 2015 Feb; 104(2):169-74. PubMed ID: 25626759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microparticles (Exosomes) and Atherosclerosis.
    Chen YT; Yuan HX; Ou ZJ; Ou JS
    Curr Atheroscler Rep; 2020 May; 22(6):23. PubMed ID: 32468443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells.
    Burger D; Touyz RM
    J Am Soc Hypertens; 2012; 6(2):85-99. PubMed ID: 22321962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease.
    Kranendonk ME; de Kleijn DP; Kalkhoven E; Kanhai DA; Uiterwaal CS; van der Graaf Y; Pasterkamp G; Visseren FL;
    Cardiovasc Diabetol; 2014 Feb; 13():37. PubMed ID: 24498934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating endothelial cells, microparticles and progenitors: towards the definition of vascular competence].
    Sabatier F; Lacroix R; Camoin-Jau L; Anfosso F; Sampol J; Dignat-George F
    Rev Med Interne; 2011 Jan; 32(1):54-63. PubMed ID: 20541851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticles: biomarkers and beyond.
    Burger D; Schock S; Thompson CS; Montezano AC; Hakim AM; Touyz RM
    Clin Sci (Lond); 2013 Apr; 124(7):423-41. PubMed ID: 23249271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.
    Amabile N; Cheng S; Renard JM; Larson MG; Ghorbani A; McCabe E; Griffin G; Guerin C; Ho JE; Shaw SY; Cohen KS; Vasan RS; Tedgui A; Boulanger CM; Wang TJ
    Eur Heart J; 2014 Nov; 35(42):2972-9. PubMed ID: 24742886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial microparticles: missing link in endothelial dysfunction?
    Yong PJ; Koh CH; Shim WS
    Eur J Prev Cardiol; 2013 Jun; 20(3):496-512. PubMed ID: 22496273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticles: a component of various diseases.
    Budaj M; Poljak Z; Ďuriš I; Kaško M; Imrich R; Kopáni M; Maruščáková L; Hulín I
    Pol Arch Med Wewn; 2012; 122 Suppl 1():24-9. PubMed ID: 23222474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of endothelial activation and dysfunction in cardiovascular diseases.
    Zhang J
    Rev Cardiovasc Med; 2022 Feb; 23(2):73. PubMed ID: 35229564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The many faces of endothelial microparticles.
    Dignat-George F; Boulanger CM
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):27-33. PubMed ID: 21160065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles, vascular function and hypertension.
    Boulanger CM
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):177-80. PubMed ID: 20051854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticles and cardiovascular diseases.
    Voukalis C; Shantsila E; Lip GYH
    Ann Med; 2019; 51(3-4):193-223. PubMed ID: 31007084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review.
    Deng F; Wang S; Zhang L
    Biomed Res Int; 2016; 2016():9802026. PubMed ID: 27803933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
    Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
    Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.